Developer docs
API playgroundTry for free, no card

Search company profiles

Grow Pharma

Full company profile

uuid002wl3n

Namestring
Grow Pharma
Legal namestring
Гроу Фарма ООД
Websiteurl
growpharma.bg
Company typeenum
Private
Founded yearstring
-
Descriptiontext

Grow Pharma OOD is a privately held Bulgarian pharmaceutical company headquartered in Sofia that develops and sells medical cosmetics and dietary supplements through its own e-commerce platform (growpharma.bg) and the Bulgarian pharmacy network. The company's portfolio centers on enzymatic formulations based on subtilisin protease, developed in collaboration with the Institute of Organic Chemistry at the Bulgarian Academy of Sciences (BAS). Its four commercial products are NEPROLYZIN G (a proteolytic enzyme gel containing subtilisin 250 CTA units per gram with chlorhexidine digluconate for cleaning purulent and necrotic wounds), POST-NEPROL (an epithelializing gel with subtilisin 200 CTA units, hydrolyzed collagen, D-panthenol, and vitamins A and E for skin and mucous membrane regeneration), TONSILIC syrup (a 200 ml immune and throat-support supplement containing beta-glucan, L-arginine, iodine, and B-complex vitamins), and Creatine STRNG (a buffered creatine supplement at pH 7.5 designed to resist stomach acid breakdown for two hours).

Short descriptiontext

Grow Pharma OOD is a Sofia-based Bulgarian pharmaceutical company that develops and sells medical cosmetics and dietary supplements based on proprietary subtilisin protease and buffered creatine formulations, distributing through its own e-commerce platform and the Bulgarian pharmacy network.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersSofia, Bulgaria
HQ citystring
Sofia
HQ countrystring
Bulgaria
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical cosmetics, dietary supplements, enzymatic wound care, subtilisin protease gels, nutritional supplements
Industry2 codes
PRIMARYHLAIAAAK
Dermatology & Aesthetics Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYCRADAGAD
Herbal & Botanical Supplements
NAICS code3 codes
  • Medicinal and Botanical Manufacturing325411
  • Soap and Cleaning Compound Manufacturing32561
  • Food (Health) Supplement Retailers456191
SIC code2 codes
  • Perfumes, Cosmetics & Other Toilet Preparations2844
  • Medicinal Chemicals & Botanical Products2833
Product category
Pharmaceutical & Dietary Supplements
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Product sales (e-commerce and pharmacy)
TypeOne Time License
Description

Grow Pharma generates revenue through direct sales of medical cosmetics and nutritional supplements via its own online store (growpharma.bg) and through the Bulgarian pharmacy network (аптечната мрежа). Products are sold as one-time purchases at fixed retail prices.

growpharma.bg
2Medical cosmetics (topical pharmaceutical gels)
TypeOne Time License
Description

Revenue from medical-grade topical gels (НЕПРОЛИЗИН Г and ПОСТ-НЕПРОЛ) sold at unit prices ranging from 9 to 31 лв. These products are distributed both online and through pharmacies.

growpharma.bg
3Nutritional supplements (liquid and powder)
TypeOne Time License
Description

Revenue from dietary supplements including TONSILIC syrup (25 лв per 200ml) and Creatine STRNG (29 лв per pack). Sold through e-commerce and pharmacy network.

growpharma.bg
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Personnel, Technology or R&D, Operations, Marketing or Sales
Pricing details4 tiers
1НЕПРОЛИЗИН гель - enzymatic gel for wound cleaning
ModelUnit PricingBilling cadencePay-as-you-go
Notes

10.00 лв. – 31.00 лв. Available in sizes: 20g, 50g, and bundle packs (Gx2, Gx4). Sold at pharmacies and online.

growpharma.bg
2ПОСТ-НЕПРОЛ гель - epithelializing gel for skin regeneration
ModelUnit PricingBilling cadencePay-as-you-go
Notes

9.00 лв. – 18.00 лв. Available in 20g and 50g sizes.

growpharma.bg
3ТОНЗИЛИК сироп 200ml - immune support syrup
ModelUnit PricingBilling cadencePay-as-you-go
Notes

25.00 лв. per 200ml bottle. For children up to 6 years: 5ml once daily on empty stomach; children over 6 and adults: 10ml once daily on empty stomach.

growpharma.bg
4Creatine STRNG - buffered creatine supplement
ModelUnit PricingBilling cadencePay-as-you-go
Notes

29.00 лв. per package (containing multiple sachets, each 5g). Recommended dose: 2 sachets (10g) daily. Dissolve in 200-300ml warm water, wait 5-6 minutes before consumption. No loading phase required.

growpharma.bg
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Grow Pharma develops and sells proprietary medical cosmetics (NEPROLYZIN G and POST-NEPROL enzymatic wound-care gels based on subtilisin protease) and dietary supplements (TONSILIC immune-support syrup and Creatine STRNG buffered creatine). All products are formulated in collaboration with the Institute of Organic Chemistry at the Bulgarian Academy of Sciences and sold to individual consumers through the company's own e-commerce platform and the Bulgarian pharmacy network.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Neprolysin has been used successfully in major Bulgarian hospitals including Pirogov, Alexandrovска, and the Military Medical Academy, saving many patients from amputation
+3 more records
Product overview1 text field

Grow Pharma offers a focused portfolio of medical cosmetics and dietary supplements developed in Bulgaria. The medical cosmetics line includes POST-NEPROL (epithelializing gel for skin/mucous membrane regeneration) and NEPROLYZIN G (proteolytic enzyme gel for wound cleaning), both based on subtilisin enzyme technology. The dietary supplements include TONSILIC syrup (immune and throat health support with vitamins and beta-glucan) and Creatine STRNG (buffered creatine for sports performance). All products are developed in collaboration with the Institute of Organic Chemistry at the Bulgarian Academy of Sciences.

Product and service4 records
1NEPROLYZIN G (НЕПРОЛИЗИН Г) enzymatic wound-cleaning gel
CategoryMedical Cosmetic — Wound Care Gel
Description

Medical-cosmetic proteolytic-enzyme gel for cleaning hard-to-heal purulent and necrotic wounds. Contains subtilisin (250 CTA units/g), glycerol, and chlorhexidine digluconate. Selectively degrades peptide bonds in necrotic tissue without affecting healthy cells. Sold in 20g and 50g sizes and bundle packs (Gx2, Gx4). For patients and clinicians treating gangrene, diabetic foot, burns, pressure ulcers (decubitus), and post-surgical wounds.

2POST-NEPROL (ПОСТ-НЕПРОЛ) epithelializing gel
CategoryMedical Cosmetic — Skin Regeneration Gel
Description

Medical-cosmetic epithelializing gel with proteolytic enzyme (subtilisin 200 CTA units) for skin and mucous-membrane regeneration, hydration and softening. Contains partially hydrolyzed sterile collagen (5%), D-Panthenol (2%), Vitamin A (15,000 IU), Vitamin E (10mg), zinc oxide, magnesium oxide, glycerol, and chlorhexidine digluconate. Available in 20g and 50g sizes. For post-wound skin regeneration and mucous-membrane care.

3TONSILIC (ТОНЗИЛИК) immune-support syrup 200ml
CategoryDietary Supplement — Immune / Throat Support
Description

200ml dietary-supplement syrup for throat and immune support, formulated with beta-glucan, L-arginine, iodine, B-complex vitamins (B2, B3, B5, B6, B9), vitamin C, and niacins. Dosing: 5ml once daily on empty stomach for children up to 6 years; 10ml once daily on empty stomach for children over 6 and adults. Targets children with underdeveloped immunity and frequent upper respiratory infections, and adults with recurrent tonsillar/throat issues.

4Creatine STRNG buffered creatine supplement
CategoryDietary Supplement — Sports Nutrition
Description

Innovative buffered creatine dietary supplement with a pH 7.5 phosphate buffer developed with the Institute of Organic Chemistry at BAS. Packaged as 5g sachets (14 sachets per package). Recommended dose: 2 sachets (10g) daily dissolved in 200–300ml warm water, waiting 5–6 minutes before consumption. Designed for athletes and fitness consumers seeking maximum creatine absorption without loading phase or kidney strain.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership2 partners
1Institute of Organic Chemistry at the Bulgarian Academy of Sciences (БАН)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Grow Pharma collaborates with the Institute of Organic Chemistry at the Bulgarian Academy of Sciences (БАН) for product development. Prof. Peter Nedkov and his team from the institute developed the Neprolysin and Post-Neprol enzymatic formulations. The buffered creatine Creatine STRNG was also created with the institute's scientific support. This partnership provides the scientific foundation for Grow Pharma's proprietary pharmaceutical and nutritional products.

growpharma.bg
2Bulgarian Hospitals (Pirogov, Alexandrovска, Military Medical Academy)
Strategic tierCoreTypeOthers
Description

Neprolysin has been used successfully in major Bulgarian hospitals including Pirogov, Alexandrovска Hospital, and the Military Medical Academy (ВМА). These institutions serve as clinical validation sites for the product's efficacy in treating gangrene and hard-to-heal wounds, with documented cases of saving patients from amputation.

growpharma.bg
Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Leading global sports nutrition brand owned by THG. Competes in creatine monohydrate and sports supplements via direct-to-consumer e-commerce, with significantly larger marketing scale and broader product portfolio than Grow Pharma's single-SKU creatine line.

TypeBroad incumbent
Description

Danish multinational with a wound and skin care division addressing pressure ulcers, diabetic foot, and post-surgical wounds. Comparable in wound-care therapeutic focus but with substantially larger R&D, regulatory, and distribution resources.

3Medline Industries
TypeBroad incumbent
Description

Privately held global medical supply manufacturer and distributor with wound-care, surgical, and skin-care categories. Competes broadly in wound management and skin regeneration, with scale and hospital-supply contracts that dwarf Grow Pharma's footprint.

TypeBroad incumbent
Description

Global medical products company specializing in advanced wound care, ostomy, and continence care. Directly competes in the chronic-wound management space served by Neprolysin G, with established hospital and home-care channels across multiple geographies.

TypeDirect peer
Description

Bulgaria's largest pharmaceutical manufacturer, also headquartered in Sofia. Directly comparable as a Bulgarian pharma company producing and distributing medicinal and consumer health products domestically, including through pharmacy networks, with similar regulatory exposure to Bulgarian and EU frameworks.

TypeRegional player
Description

Regional pharmaceutical distributor and consumer health brand in the Western Balkans. Comparable as a smaller-scale CEE pharma company distributing through pharmacy channels, though focused on distribution rather than proprietary formulation.

TypeDirect peer
Description

Polish sports nutrition brand specializing in creatine, protein, and performance supplements. Directly competes in the creatine category targeted by Creatine STRNG, with comparable mass-market pricing strategy and pharmacy/online distribution in CEE markets.

TypeBroad incumbent
Description

Global leader in wound care and surgical solutions. Competes in the same wound-care category (necrotic/ulcer management) with hospital-channel distribution, but operates at significantly greater scale with broader portfolios across dressings, antiseptics, and OR solutions.

TypeDirect peer
Description

Bulgarian pharmaceutical company focused on generics and consumer health products. Operates in the same domestic market with overlapping pharmacy distribution and similar regulatory positioning under Bulgarian and EU pharmaceutical frameworks.

TypeBroad incumbent
Description

Multinational medical device company with a sizable Advanced Wound Management division. Comparable in addressing chronic wounds, burns, and diabetic foot ulcers, but with global scale, extensive clinical-trial data, and diversified product lines beyond Grow Pharma's focused enzymatic gel portfolio.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Grow Pharma

Pharmaceutical & Dietary Supplementsgrowpharma.bg

Grow Pharma OOD is a Sofia-based Bulgarian pharmaceutical company that develops and sells medical cosmetics and dietary supplements based on proprietary subtilisin protease and buffered creatine formulations, distributing through its own e-commerce platform and the Bulgarian pharmacy network.

What Grow Pharma does

Grow Pharma OOD is a privately held Bulgarian pharmaceutical company headquartered in Sofia that develops and sells medical cosmetics and dietary supplements through its own e-commerce platform (growpharma.bg) and the Bulgarian pharmacy network. The company's portfolio centers on enzymatic formulations based on subtilisin protease, developed in collaboration with the Institute of Organic Chemistry at the Bulgarian Academy of Sciences (BAS). Its four commercial products are NEPROLYZIN G (a proteolytic enzyme gel containing subtilisin 250 CTA units per gram with chlorhexidine digluconate for cleaning purulent and necrotic wounds), POST-NEPROL (an epithelializing gel with subtilisin 200 CTA units, hydrolyzed collagen, D-panthenol, and vitamins A and E for skin and mucous membrane regeneration), TONSILIC syrup (a 200 ml immune and throat-support supplement containing beta-glucan, L-arginine, iodine, and B-complex vitamins), and Creatine STRNG (a buffered creatine supplement at pH 7.5 designed to resist stomach acid breakdown for two hours).

Grow Pharma firmographics

Firmographics
Name
Grow Pharma
Legal name
Гроу Фарма ООД
Website
https://growpharma.bg
Company type
Private
Operating status
Operating
Headcount range
1–10 employees
Short description
Grow Pharma OOD is a Sofia-based Bulgarian pharmaceutical company that develops and sells medical cosmetics and dietary supplements based on proprietary subtilisin protease and buffered creatine formulations, distributing through its own e-commerce platform and the Bulgarian pharmacy network.
Ownership category
akta.pro rank

Grow Pharma industry classification

Industry
Product category
Pharmaceutical & Dietary Supplements
NAICS
Medicinal and Botanical Manufacturing (325411), Soap and Cleaning Compound Manufacturing (32561), Food (Health) Supplement Retailers (456191)
SIC
Perfumes, Cosmetics & Other Toilet Preparations (2844), Medicinal Chemicals & Botanical Products (2833)
akta.pro industry
PRIMARYHLAIAAAK
Dermatology & Aesthetics Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYCRADAGAD
Herbal & Botanical Supplements

Keywords

  • Medical cosmetics
  • Dietary supplements
  • Enzymatic wound care
  • Subtilisin protease gels
  • Nutritional supplements

Where Grow Pharma is headquartered

Location

Headquarters

HQ city
Sofia
HQ country
Bulgaria
HQ region
Europe

Offices1 record

Markets served

Grow Pharma business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

  1. Product sales (e-commerce and pharmacy): Grow Pharma generates revenue through direct sales of medical cosmetics and nutritional supplements via its own online store (growpharma.bg) and through the Bulgarian pharmacy network (аптечната мрежа). Products are sold as one-time purchases at fixed retail prices.
  2. Medical cosmetics (topical pharmaceutical gels): Revenue from medical-grade topical gels (НЕПРОЛИЗИН Г and ПОСТ-НЕПРОЛ) sold at unit prices ranging from 9 to 31 лв. These products are distributed both online and through pharmacies.
  3. Nutritional supplements (liquid and powder): Revenue from dietary supplements including TONSILIC syrup (25 лв per 200ml) and Creatine STRNG (29 лв per pack). Sold through e-commerce and pharmacy network.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goНЕПРОЛИЗИН гель - enzymatic gel for wound cleaning
Unit PricingPay-as-you-goПОСТ-НЕПРОЛ гель - epithelializing gel for skin regeneration
Unit PricingPay-as-you-goТОНЗИЛИК сироп 200ml - immune support syrup
Unit PricingPay-as-you-goCreatine STRNG - buffered creatine supplement

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Grow Pharma product offering

Product offering

Core offering

Grow Pharma develops and sells proprietary medical cosmetics (NEPROLYZIN G and POST-NEPROL enzymatic wound-care gels based on subtilisin protease) and dietary supplements (TONSILIC immune-support syrup and Creatine STRNG buffered creatine). All products are formulated in collaboration with the Institute of Organic Chemistry at the Bulgarian Academy of Sciences and sold to individual consumers through the company's own e-commerce platform and the Bulgarian pharmacy network.

Product overview

Grow Pharma offers a focused portfolio of medical cosmetics and dietary supplements developed in Bulgaria. The medical cosmetics line includes POST-NEPROL (epithelializing gel for skin/mucous membrane regeneration) and NEPROLYZIN G (proteolytic enzyme gel for wound cleaning), both based on subtilisin enzyme technology. The dietary supplements include TONSILIC syrup (immune and throat health support with vitamins and beta-glucan) and Creatine STRNG (buffered creatine for sports performance). All products are developed in collaboration with the Institute of Organic Chemistry at the Bulgarian Academy of Sciences.

Differentiator

Problem solved

Functional benefit

Products and services

  • NEPROLYZIN G (НЕПРОЛИЗИН Г) enzymatic wound-cleaning gel Medical-cosmetic proteolytic-enzyme gel for cleaning hard-to-heal purulent and necrotic wounds. Contains subtilisin (250 CTA units/g), glycerol, and chlorhexidine digluconate. Selectively degrades peptide bonds in necrotic tissue without affecting healthy cells. Sold in 20g and 50g sizes and bundle packs (Gx2, Gx4). For patients and clinicians treating gangrene, diabetic foot, burns, pressure ulcers (decubitus), and post-surgical wounds.
  • POST-NEPROL (ПОСТ-НЕПРОЛ) epithelializing gel Medical-cosmetic epithelializing gel with proteolytic enzyme (subtilisin 200 CTA units) for skin and mucous-membrane regeneration, hydration and softening. Contains partially hydrolyzed sterile collagen (5%), D-Panthenol (2%), Vitamin A (15,000 IU), Vitamin E (10mg), zinc oxide, magnesium oxide, glycerol, and chlorhexidine digluconate. Available in 20g and 50g sizes. For post-wound skin regeneration and mucous-membrane care.
  • TONSILIC (ТОНЗИЛИК) immune-support syrup 200ml 200ml dietary-supplement syrup for throat and immune support, formulated with beta-glucan, L-arginine, iodine, B-complex vitamins (B2, B3, B5, B6, B9), vitamin C, and niacins. Dosing: 5ml once daily on empty stomach for children up to 6 years; 10ml once daily on empty stomach for children over 6 and adults. Targets children with underdeveloped immunity and frequent upper respiratory infections, and adults with recurrent tonsillar/throat issues.
  • Creatine STRNG buffered creatine supplement Innovative buffered creatine dietary supplement with a pH 7.5 phosphate buffer developed with the Institute of Organic Chemistry at BAS. Packaged as 5g sachets (14 sachets per package). Recommended dose: 2 sachets (10g) daily dissolved in 200–300ml warm water, waiting 5–6 minutes before consumption. Designed for athletes and fitness consumers seeking maximum creatine absorption without loading phase or kidney strain.

Quantifiable outcome

  • Neprolysin has been used successfully in major Bulgarian hospitals including Pirogov, Alexandrovска, and the Military Medical Academy, saving many patients from amputation
  • +3 more outcomes

Companies that use Grow Pharma

Customer profile

Segments4 records

Ideal customer profiles4 records

Grow Pharma technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Grow Pharma partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • Institute of Organic Chemistry at the Bulgarian Academy of Sciences (БАН)coreStrategic or Co-development PartnerGrow Pharma collaborates with the Institute of Organic Chemistry at the Bulgarian Academy of Sciences (БАН) for product development. Prof. Peter Nedkov and his team from the institute developed the Neprolysin and Post-Neprol enzymatic formulations. The buffered creatine Creatine STRNG was also created with the institute's scientific support. This partnership provides the scientific foundation for Grow Pharma's proprietary pharmaceutical and nutritional products.
  • Bulgarian Hospitals (Pirogov, Alexandrovска, Military Medical Academy)coreOthersNeprolysin has been used successfully in major Bulgarian hospitals including Pirogov, Alexandrovска Hospital, and the Military Medical Academy (ВМА). These institutions serve as clinical validation sites for the product's efficacy in treating gangrene and hard-to-heal wounds, with documented cases of saving patients from amputation.

Scale indicators1 record

Recent moves5 records

Expansion highlights4 records

Grow Pharma competitors and assessment

Company assessment

Broad incumbents

  • Myprotein: Leading global sports nutrition brand owned by THG. Competes in creatine monohydrate and sports supplements via direct-to-consumer e-commerce, with significantly larger marketing scale and broader product portfolio than Grow Pharma's single-SKU creatine line.
  • Coloplast: Danish multinational with a wound and skin care division addressing pressure ulcers, diabetic foot, and post-surgical wounds. Comparable in wound-care therapeutic focus but with substantially larger R&D, regulatory, and distribution resources.
  • Medline Industries: Privately held global medical supply manufacturer and distributor with wound-care, surgical, and skin-care categories. Competes broadly in wound management and skin regeneration, with scale and hospital-supply contracts that dwarf Grow Pharma's footprint.
  • ConvaTec Group: Global medical products company specializing in advanced wound care, ostomy, and continence care. Directly competes in the chronic-wound management space served by Neprolysin G, with established hospital and home-care channels across multiple geographies.
  • Mölnlycke Health Care: Global leader in wound care and surgical solutions. Competes in the same wound-care category (necrotic/ulcer management) with hospital-channel distribution, but operates at significantly greater scale with broader portfolios across dressings, antiseptics, and OR solutions.
  • Smith & Nephew: Multinational medical device company with a sizable Advanced Wound Management division. Comparable in addressing chronic wounds, burns, and diabetic foot ulcers, but with global scale, extensive clinical-trial data, and diversified product lines beyond Grow Pharma's focused enzymatic gel portfolio.

Direct peers

  • Sopharma AD: Bulgaria's largest pharmaceutical manufacturer, also headquartered in Sofia. Directly comparable as a Bulgarian pharma company producing and distributing medicinal and consumer health products domestically, including through pharmacy networks, with similar regulatory exposure to Bulgarian and EU frameworks.
  • Olimp Labs: Polish sports nutrition brand specializing in creatine, protein, and performance supplements. Directly competes in the creatine category targeted by Creatine STRNG, with comparable mass-market pricing strategy and pharmacy/online distribution in CEE markets.
  • Tchaikapharma: Bulgarian pharmaceutical company focused on generics and consumer health products. Operates in the same domestic market with overlapping pharmacy distribution and similar regulatory positioning under Bulgarian and EU pharmaceutical frameworks.

Regional players

  • Abela Pharma: Regional pharmaceutical distributor and consumer health brand in the Western Balkans. Comparable as a smaller-scale CEE pharma company distributing through pharmacy channels, though focused on distribution rather than proprietary formulation.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Grow Pharma social profiles

Digital presence

Grow Pharma compliance and trust

Trust signal

Compliance2 records

Grow Pharma financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Grow Pharma leadership team

Management profile

Number of profiles

Profiles4 records

Grow Pharma funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Grow Pharma M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Grow Pharma

What does Grow Pharma do?

Grow Pharma develops and sells proprietary medical cosmetics (NEPROLYZIN G and POST-NEPROL enzymatic wound-care gels based on subtilisin protease) and dietary supplements (TONSILIC immune-support syrup and Creatine STRNG buffered creatine). All products are formulated in collaboration with the Institute of Organic Chemistry at the Bulgarian Academy of Sciences and sold to individual consumers through the company's own e-commerce platform and the Bulgarian pharmacy network.

Is Grow Pharma a public or private company?

Grow Pharma is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Grow Pharma founded?

Grow Pharma was founded in -1. It employs 1 to 10 people.

Where is Grow Pharma based?

Grow Pharma is headquartered in Sofia, Bulgaria, in the Europe region.

How does Grow Pharma make money?

Three revenue lines are on record. Product sales (e-commerce and pharmacy) is the primary driver. The others are medical cosmetics (topical pharmaceutical gels) and nutritional supplements (liquid and powder).

Who are Grow Pharma's main competitors?

Broad incumbents on record are Myprotein, Coloplast, Medline Industries, ConvaTec Group, Mölnlycke Health Care and Smith & Nephew. Direct peers are Sopharma AD, Olimp Labs and Tchaikapharma. Abela Pharma is listed as a regional player.

Does Grow Pharma have an API?

No public API is recorded for Grow Pharma.

What industry is Grow Pharma in?

Grow Pharma's product category is Pharmaceutical & Dietary Supplements. Its primary akta.pro industry code is HLAIAAAK, Dermatology & Aesthetics Pharmaceuticals, with a secondary code of CRADAGAD, Herbal & Botanical Supplements. Its NAICS code is 325411 and its SIC code is 2844.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals